The lure of orphan products
This article was originally published in Scrip
Executive Summary
The global market for orphan drugs was worth almost $85 billion in 2009. Furthermore, the market is predicted to grow at a compound annual rate of around 6% over the next few years, which is at least as good as the growth achieved by some of the top companies in recent years.